"Major new drug creation" special to encourage major varieties of research and development and industrialization
-
Last Update: 2020-06-03
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Business Agency, March 14
Ministry of Health, the Ministry of Health after the 13th issued the "major new drug creation" science and technology major special "12th Five-Year Plan" implementation plan for 2014 new project declaration guidelines, put forward the focus of support with significant goal-oriented and good operating mechanism of integrated topics, priority support enterprises to lead the joint university and scientific research institutions to achieve industrialization as the goal of substantive joint applicationsguidelines suggest that priority is given to selecting the backbone of the industry's strengths
enterprises to, and promote their completion of major varieties of research and development and industrializationCore technology research and development must be combined with product development and platform buildingguidelines suggest that, in view of the multiple morbidity and common diseases that seriously endanger people's health
and, such as pediatric diseases and geriatric diseases, the independent creation or technological transformation conforms to the requirements of the principle of "cultivating major products, meeting important needs and solving key problems"Among them, chemical drugs include anti-multi-drug resistance bacteria, broad-spectrum antivirals, mental disorders, cardiovascular and immune, anti-
tumor, metabolicdiseasesand other new targets with independent intellectual property rights, new technology drugs, to meet the clinical and industrial needs of patent expired drugs imitation and re-innovation, re-positioning of candidate drugs; , after the development of the side, component Chinese medicine, Chinese medicine international registration research, Chinese medicine injection safety system evaluation and large variety of drugs after the market evaluation;
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.